Ampa/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis

Annals of the Rheumatic Diseases

Volumn 74, Issue 1, 2015, Pages 242-251

  Bonnet, Cleo S ^a   Williams, Anwen S ^b   Gilbert, Sophie J ^a   Harvey, Ann K ^b   Evans, Bronwen A ^b   Mason, Deborah J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; AMPA RECEPTOR; INTERLEUKIN 6; KAINIC ACID RECEPTOR; MESSENGER RNA; 2,3-DIOXO-6-NITRO-7-SULFAMOYLBENZO(F)QUINOXALINE; AMINO ACID RECEPTOR BLOCKING AGENT; QUINOXALINE DERIVATIVE;

ANIMAL TISSUE; ANTIGEN INDUCED ARTHRITIS; ARTHRITIS; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; DEGRADATION; DRUG EFFICACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MINERALIZATION; MONONUCLEAR CELL; NONHUMAN; OSTEOARTHRITIS; OSTEOBLAST; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVITIS; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; ARTICULAR CARTILAGE; DRUG EFFECTS; EXPERIMENTAL ARTHRITIS; IMMUNOLOGY; INFLAMMATION; KNEE; KNEE MENISCUS; MALE; METABOLISM; PAIN; RADIOGRAPHY; SYNOVIUM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BEHAVIOR, ANIMAL; CARTILAGE, ARTICULAR; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-6; KNEE JOINT; MALE; MENISCI, TIBIAL; OSTEOARTHRITIS; OSTEOBLASTS; PAIN; QUINOXALINES; RATS; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; SYNOVIAL MEMBRANE;

EID: 84918503361     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203670     Document Type: Article

References (61)

1. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 2005;44:7-16.
2. Ashraf S, Walsh DA. Angiogenesis in osteoarthritis. Curr Opin Rheumatol 2008;20:573-80.
3. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013;21:16-21.
4. Colmegna I, Ohata BR, Menard HA. Current understanding of rheumatoid arthritis therapy. Clin Pharmacol Ther 2012;91:607-20.
5. Cheng DS, Visco CJ. Pharmaceutical therapy for osteoarthritis. Pm R 2012;4 (5 suppl):S82-8.
6. Hameed F, Ihm J. Injectable medications for osteoarthritis. Pm R 2012;4 (5 suppl):S75-81.
7. Verbruggen G, Wittoek R, Vander Cruyssen B, et al. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis 2012;71:891-8.
8. Chevalier X, Goupille P, Beaulieu AD, et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009;61:344-52.
9. Maksymowych WP, Russell AS, Chiu P, et al. Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee. Arthritis Res Ther 2012;14:R206.
10. McNearney T, Speegle D, Lawand N, et al. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 2000;27:739-45.
11. Lawand NB, McNearney T, Westlund KN. Amino acid release into the knee joint: key role in nociception and inflammation. Pain 2000;86:69-74.
12. Jean YH, Wen ZH, Chang YC, et al. Increased concentrations of neuro-excitatory amino acids in rat anterior cruciate ligament-transected knee joint dialysates: a microdialysis study. J Orthop Res 2005;23:569-75.
13. McNearney T, Baethge BA, Cao S, et al. Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol 2004;137:621-7.
14. McNearney TA, Ma Y, Chen Y, et al. A peripheral neuroimmune link: glutamate agonists upregulate NMDA NR1 receptor mRNA and protein, vimentin, TNF-alpha, and RANTES in cultured human synoviocytes. Am J Physiol Regul Integr Comp Physiol 2010;298:R584-98.
15. Hinoi E, Yoneda Y. Possible involvement of glutamatergic signaling machineries in pathophysiology of rheumatoid arthritis. J Pharmacol Sci 2011;116:248-56.
16. Brakspear KS, Mason DJ. Glutamate signaling in bone. Front Endocrinol (Lausanne) 2012;3:97.
17. Skerry TM. The role of glutamate in the regulation of bone mass and architecture. J Musculoskelet Neuronal Interact 2008;8:166-73.
18. Piepoli T, Mennuni L, Zerbi S, et al. Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression. Osteoarthritis Cartilage 2009;17:1076-83.
19. Morimoto R, Uehara S, Yatsushiro S, et al. Secretion of L-glutamate from osteoclasts through transcytosis. Embo J 2006;25:4175-86.
20. Flood S, Parri R, Williams A, et al. Modulation of interleukin-6 and matrix metalloproteinase 2 expression in human fibroblast-like synoviocytes by functional ionotropic glutamate receptors. Arthritis Rheum 2007;56:2523-34.
21. Lindblad SS, Mydel P, Hellvard A, et al. The N-methyl-d-aspartic acid receptor antagonist memantine ameliorates and delays the development of arthritis by enhancing regulatory T cells. Neurosignals 2012;20:61-71.
22. Miller KE, Hoffman EM, Sutharshan M, et al. Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms. Pharmacol Ther 2011;130:283-309.
23. Parada-Turska J, Rzeski W, Majdan M, et al. Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro. Eur J Pharmacol 2006;535:95-7.
24. Parada-Turska J, Rzeski W, Zgrajka W, et al. Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro. Rheumatol Int 2006;26:422-6.
25. Zhang GH, Yoon YW, Lee KS, et al. The glutamatergic N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the joint contribute to the induction, but not maintenance, of arthritic pain in rats. Neurosci Lett 2003;351:177-80.
26. Gangadharan V, Wang R, Ulzhofer B, et al. Peripheral calcium-permeable AMPA receptors regulate chronic inflammatory pain in mice. J Clin Invest 2011;121:1608-23.
27. Lam FF, Ng ES. Substance P and glutamate receptor antagonists improve the anti-arthritic actions of dexamethasone in rats. Br J Pharmacol 2010;159:958-69.
28. Alonzi T, Fattori E, Lazzaro D, et al. Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 1998;187:461-8.
29. Williams AS, Topley N, Dojcinov S, et al. Amelioration of rat antigen-induced arthritis by liposomally conjugated methotrexate is accompanied by down-regulation of cytokine mRNA expression. Rheumatology (Oxford) 2001;40:375-83.
30. Haywood L, McWilliams DF, Pearson CI, et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003;48:2173-7.
31. Nowell MA, Williams AS, Carty SA, et al. Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol 2009;182:613-22.
32. Walsh DA, Bonnet CS, Turner EL, et al. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage 2007;15:743-51.
33. Wang N, Robaye B, Agrawal A, et al. Reduced bone turnover in mice lacking the P2Y (13) receptor of ADP. Mol Endocrinol 2012;26:142-52.
34. Klein A, Wessolleck J, Papazoglou A, et al. Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats. Behav Brain Res 2009;199:317-25.
35. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
36. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004;64:5245-50.
37. Gharibi B, Abraham AA, Ham J, et al. Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes. J Bone Miner Res 2011;26:2112-24.
38. Revell PA, Mayston V, Lalor P, et al. The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis 1988;47:300-7.
39. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903-11.
40. Boettger MK, Hensellek S, Richter F, et al. Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum 2008;58:2368-78.
41. Boettger MK, Weber K, Grossmann D, et al. Spinal tumor necrosis factor alpha neutralization reduces peripheral inflammation and hyperalgesia and suppresses autonomic responses in experimental arthritis: a role for spinal tumor necrosis factor alpha during induction and maintenance of peripheral inflammation. Arthritis Rheum 2010;62:1308-18.
42. Coulthard LG, Costello J, Robinson B, et al. Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis. Arthritis Res Ther 2011;13:R42.
43. Kraus VB, Birmingham J, Stabler TV, et al. Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage 2012;20:271-8.
44. Cohen SB, Proudman S, Kivitz AJ, et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther 2011;13:R125.
45. Lin TH, Yang RS, Tang CH, et al. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate. Eur J Pharmacol 2008;589:37-44.
46. Szczesniak AM, Gilbert RW, Mukhida M, et al. Mechanical loading modulates glutamate receptor subunit expression in bone. Bone 2005;37:63-73.
47. Wang L, Hinoi E, Takemori A, et al. Release of endogenous glutamate by AMPA receptors expressed in cultured rat costal chondrocytes. Biol Pharm Bull 2005;28:990-3.
48. Roth A, Mollenhauer J, Wagner A, et al. Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis. Arthritis Res Ther 2005;7:R677-86.
49. Nissler K, Pohlers D, Huckel M, et al. Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation. Ann Rheum Dis 2004;63:1470-7.
50. Pedersen HE. The ossicles of the semilunar cartilages of rodents. Anat Rec 1949;105:1-9.
51. Guerne PA, Carson DA, Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 1990;144:499-505.
52. Evans BA, Elford C, Pexa A, et al. Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin. J Bone Miner Res 2006;21:228-36.
53. Cheung J, Mak YT, Papaioannou S, et al. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. J Endocrinol 2003;177:423-33.
54. Min SS, Han JS, Kim YI, et al. A novel method for convenient assessment of arthritic pain in voluntarily walking rats. Neurosci Lett 2001;308:95-8.
55. Burford JH, Perrien DS, Horner A, et al. Glutamate signalling regulates skeletogenesis and bone growth. J Bone Miner Res 2004;19:S212-S3.
56. Byron CR, Barger AM, Stewart AA, et al. In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. Am J Vet Res 2010;71:615-22.
57. Carda C, Silvestrini G, Gomez De Ferraris ME, et al. Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint. Tissue Cell 2005;37:247-55.
58. Herrling P. ed. Excitatory amino acids: clinical results with antagonists. Academic Press, 1997.
59. Dal D, Tetik O, Altunkaya H, et al. The efficacy of intra-articular ketamine for postoperative analgesia in outpatient arthroscopic surgery. Arthroscopy 2004;20:300-5.
60. Ingwersen SH, Ohrstrom JK, Petersen P, et al. Human Pharmacokinetics of the Neuroprotective Agent NBQX. Am J Ther 1994;1:296-303.
61. Cavalheiro EA, Olney JW. Glutamate antagonists: deadly liaisons with cancer. Proc Natl Acad Sci USA 2001;98:5947-8.